在非劣等性试验中解决控制风险问题
Ian R White1, Matteo Quartagno1, Abdel G Babiker1
1MRC Clinical Trials Unit at UCL, London, UK.
BMJ medicine
|August 4, 2025
概括
非劣势性试验评估新疗法与标准护理相比. 这项研究解决了控制风险的挑战,提供了确保可靠临床证据的试验功率和可解释性的方法.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 基于证据的医学基于证据的医学.
背景情况:
- 非劣势性试验将新干预措施与标准护理进行比较,特别是当新选择提供诸如降低毒性或成本等好处时.
- 这些试验的统计能力和可解释性对对照风险高度敏感,定义为标准护理组的结果频率.
- 当控制风险出乎意料地低或高时,就会出现挑战,这可能会使试验不足或无法解释.
研究的目的:
- 识别和解决与非劣势试验设计和分析中控制风险相关的关键问题.
- 提供实用策略来保持统计能力,并确保非劣势性试验结果的可解释性.
- 引导研究人员选择适当的效果测量方法,并将试验设计适应控制风险的潜在变化.
主要方法:
- 该研究概述了在非劣势性试验中控制风险的两个主要挑战.
- 它提出了两个关键策略: 1) 仔细选择非劣势差额的效果测量方法,考虑临床背景和样本大小的影响; 2) 积极规划观察到的控制风险与设计阶段估计的潜在偏差.
- 介绍了在试验分析过程中调整非劣势差额的统计原则.
主要成果:
- 效果测量的选择显著影响所需的样本大小,影响试验功率.
- 展示了不同的效果测量如何导致更小或更大的样本大小要求.
- 提供了一个统计学上合理的框架,用于在分析阶段调整非劣势差额,以适应观察到的控制风险变化.
结论:
- 仔细考虑效果测量及其与控制风险的关系对于设计具有足够功率和可解释的非劣等性试验至关重要.
- 调查人员必须预见并计划预期和观察到的控制风险之间的潜在差异.
- 在分析过程中对非劣势差额进行统计原则上的调整对于稳健的试验结果至关重要.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:25Strategies for Assessing and Addressing Confounding
155
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
155
01:11Blinding
2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
01:13Controls in Experiments
11.2K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
11.2K
01:27Confounding in Epidemiological Studies
262
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
262
01:12Relative Risk
347
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
347